|
ZBTB6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.77280000024771E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.454799999969E-06 |
| Normal-vs-Stage2 |
3.205700E-04 |
| Normal-vs-Stage3 |
2.96319999981698E-07 |
| Normal-vs-Stage4 |
3.85559995041973E-09 |
| Stage1-vs-Stage2 |
9.011600E-01 |
| Stage1-vs-Stage3 |
1.441370E-01 |
| Stage1-vs-Stage4 |
3.475900E-03 |
| Stage2-vs-Stage3 |
2.872200E-01 |
| Stage2-vs-Stage4 |
2.242400E-02 |
| Stage3-vs-Stage4 |
8.451800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.26600000050337E-07 |
| Normal-vs-AfricanAmerican |
4.937600E-03 |
| Normal-vs-Asian |
3.91369999996893E-06 |
| Caucasian-vs-AfricanAmerican |
4.865600E-01 |
| Caucasian-vs-Asian |
9.257800E-01 |
| AfricanAmerican-vs-Asian |
4.894400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.94700000017068E-07 |
| Normal-vs-Female |
1.13130000001238E-06 |
| Male-vs-Female |
3.605400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52793999999012E-05 |
| Normal-vs-Age(41-60Yrs) |
7.77400000040451E-07 |
| Normal-vs-Age(61-80Yrs) |
4.95899999952698E-07 |
| Normal-vs-Age(81-100Yrs) |
1.192330E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.303600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.323400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.475400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.768400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.990400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.537000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.979600E-02 |
| Classical-VS-Follicular |
2.337200E-01 |
| Classical-VS-Other |
2.848800E-01 |
| Classical-VS-Normal |
1.63624999999223E-05 |
| Tall-VS-Follicular |
3.885200E-01 |
| Tall-VS-Other |
8.860800E-01 |
| Tall-VS-Normal |
5.40579999985802E-07 |
| Follicular-VS-Other |
5.623800E-01 |
| Follicular-VS-Normal |
4.73269999967663E-07 |
| Other-VS-Normal |
1.196470E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.05590000001976E-06 |
| Normal-vs-N1 |
1.35219999641834E-08 |
| N0-vs-N1 |
2.333900E-02 |
|
|
